Lumira Ventures today announced the first closing of Lumira Ventures V, LP ("Fund V"), its latest healthcare venture capital fund dedicated to building transformative biotechnology and medical technology companies across North America. Together with three strategic funds managed by the firm, this closing represents the seventh investment fund established by Lumira. With a target final size of US$200 million (C$275 million), Fund V has already completed its first investment, a US$52 million Series B financing for a pre-commercial-stage medical device company.
We are the venture capital agency of the government of Ontario
Venture Ontario is the venture capital investment agency of the government of Ontario. Venture Ontario was created to promote and develop the venture capital sector in Ontario, to assist high potential technology companies access capital vital to grow and prosper.
Venture Ontario News
The latest news from Venture Ontario
August 7, 2025
HistoSonics Announces $2.25B Acquisition by Consortium of Top-Tier Investors
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced a management-led majority stake acquisition by a syndicate of globally recognized private and public investors, including K5 Global, Bezos Expeditions, Wellington Management and other new and existing investors.
June 11, 2025
Genesys Capital is closing its largest fund to date – Genesys Ventures IV LP
Genesys Capital (“Genesys”) is pleased to announce the upcoming closing of Genesys Ventures IV LP (“Fund IV” or the “fund”) to continue its successful track record of building Canadian life science companies in both the medtech and biotech sectors.
